ICU Medical Stock Forecast

Stock Price Forecast

According to 8 analysts polled by S&P Global, ICU Medical stock has a consensus rating of "Buy" and an average price target of $172.5. The average 1-year stock price forecast is 26.48% higher than the current stock price, while the lowest is $160 (+17.31%) and the highest is $200 (+46.64%).

Price Target: $172.5 (+26.48%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$160	$172.5	$167.5	$200
Change	+17.31%	+26.48%	+22.81%	+46.64%

Analyst Ratings

The average analyst rating for ICU Medical stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Jan '26	Feb '26	Mar '26	Apr '26	May '26	Jun '26
Strong Buy	3	3	3	3	3	4
Buy	2	3	3	3	4	4
Hold	2	1	1	1	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	7	7	7	7	7	8

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Sam Eiber BTIG	BTIG	Buy Initiates $170	Buy	Initiates	$170	+24.64%	Jun 15, 2026
Jason Bednar Piper Sandler	Piper Sandler	Buy Maintains $163	Buy	Maintains	$163	+19.51%	Jun 10, 2026
Michael Matson Needham	Needham	Buy Upgrades $165	Buy	Upgrades	$165	+20.98%	May 27, 2026
Brett Fishbin KeyBanc	KeyBanc	Buy Reiterates $164	Buy	Reiterates	$164	+20.24%	May 8, 2026

Financial Forecast

Revenue This Year

2.17B

from 2.23B

-2.61%

from 2.23B

Revenue Next Year

2.27B

from 2.17B

4.51%

from 2.17B

EPS This Year

8.16

from 7.76

5.12%

from 7.76

EPS Next Year

9.30

from 8.16

14.04%

from 8.16

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	1.32B	2.28B	2.26B	2.38B	2.23B	2.17B
Revenue Growth	3.56%	73.21%	-0.92%	5.44%	-6.33%	-2.61%
Gross Profit	491.49M	697.76M	739.87M	824.78M	822.04M	889.06M
Gross Margin	37.34%	30.60%	32.75%	34.62%	36.84%	40.91%
Operating Income	141.41M	-3.57M	47.84M	97.41M	109.33M	350.40M
Net Income	103.14M	-74.29M	-29.66M	-117.69M	732.00K	74.73M
EPS	-	-	-	-	7.76	8.16
EPS Growth	-	-	-	-	24.76%	5.12%
Forward PE	47.09	-	-	-	178.72	16.72
Free Cash Flow	176.31M	-144.11M	162.25M	75.80M	393.45M	170.00M
No. Analysts	-	-	-	-	-	7

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue	2026	2027	2028
High	2.2B
Avg	2.2B
Low	2.2B

Revenue Growth

Revenue Growth	2026	2027	2028
High	-2.0%
Avg	-2.6%
Low	-3.1%

EPS Forecast

EPS	2026	2027	2028
High	8.20
Avg	8.16
Low	8.08

EPS Growth

EPS Growth	2026	2027	2028
High	5.7%
Avg	5.1%
Low	4.1%